MoneyWorks4Me

Morepen Laboratories - Quaterly Results

21 May 2024 Evaluate
The revenue zoomed 16.66% to Rs. 3926.00 millions for the quarter ended March 2024 as compared to Rs. 3365.24 millions during the corresponding quarter last year.Net Profit witnessed a 288.90% growth almost the double from Rs. 102.75 millions to Rs. 399.59  millions  of same quarter last year.Operating profit surged to 601.22 millions from the corresponding previous quarter of 181.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3926.00 3365.24 16.66 15375.94 13388.83 14.84 15375.94 13388.83 14.84
Other Income 39.86 29.88 33.40 125.66 57.59 118.20 125.66 57.59 118.20
PBIDT 601.22 181.17 231.85 1743.84 830.29 110.03 1743.84 830.29 110.03
Interest 7.28 5.62 29.54 35.09 19.81 77.13 35.09 19.81 77.13
PBDT 593.94 175.55 238.33 1708.75 810.48 110.83 1708.75 810.48 110.83
Depreciation 66.88 46.14 44.95 219.00 180.06 21.63 219.00 180.06 21.63
PBT 527.06 129.41 307.28 1489.75 630.42 136.31 1489.75 630.42 136.31
TAX 127.47 26.66 378.13 380.40 167.99 126.44 380.40 167.99 126.44
Deferred Tax -4.36 2.03 -314.78 -4.36 2.03 -314.78 -4.36 2.03 -314.78
PAT 399.59 102.75 288.90 1109.35 462.43 139.90 1109.35 462.43 139.90
Equity 1022.27 1022.27 0.00 1022.27 1022.27 0.00 1022.27 1022.27 0.00
PBIDTM(%) 15.31 5.38 184.45 11.34 6.20 82.88 11.34 6.20 82.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..